Clinical Trial Update: Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG

View source ↗

Summary

A clinical trial update indicates the fimasartan study for hypertensive cardiac disease with left ventricular hypertrophy (ECG-estimated) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Left Ventricular Hypertrophy, Hypertension | Status: COMPLETED